Press Release

Precise treatment: ZEISS EyeMag Medical Loupes

With a broad portfolio of medical loupes, ZEISS offers an ideal entry into microsurgical dentistry.

20 March 2025

Jena, Germany | March 20, 2025 | Carl Zeiss Meditec AG

At the International Dental Show (IDS) 2025, ZEISS Medical Technology will present its portfolio of magnifying loups: EyeMag^® Medical Loupes from ZEISS are characterized by first-class optics and various magnification options that meet the different requirements in dental practices. The ZEISS EyeMag Family portfolio includes a wide selection of lightweight frames for maximum comfort.

"For more than 100 years, ZEISS has been offering medical loupes that are used in a wide variety of specialties and support more precise treatment," says Florina Demaj, Head of the Dental Business Sector of ZEISS Medical Technology. "With the high-quality ZEISS optics, the ZEISS EyeMag Family portfolio is the ideal entry into microsurgical dentistry."

ZEISS EyeMag Smart TTL
ZEISS EyeMag Family
ZEISS EXTARO 300
ZEISS OPMI PROergo

Redesigned optics

In dentistry, seeing tiny anatomical structures in detail is essential for a successful treatment. Medical loupes increase the field of view and thus support the accuracy and safety of the procedures. The redesigned and high-quality optics of the ZEISS EyeMag Family stand out thanks to their precise visualization of even the smallest details:

The large field of view and depth of field of the Galilean optics enable easy visualization of the entire treatment area. Select between the versatile flip-up and individualized system. Available with 2.0x, 2.5x or 3.0x magnification, they are the ideal choice for wearers looking for a light medical loupe with basic magnification. The Kepler optics provide high-contrast stereoscopic images for detail recognition and differentiation. They feature various magnification levels ranging from 3.2x up to 5x, making them the perfect selection for wearers with higher magnification needs.

Designed for individual needs

With its broad portfolio, ZEISS offers suitable medical loupes with an individual working distance for every customer. They support an ergonomic posture and reduce the stress on the back, neck and shoulders. The models are available as customized versions or flip-up systems and can be complemented with powerful LED illumination from ZEISS.

Visitors to the IDS can see the excellent optical performance and various configuration options of ZEISS medical loupes for themselves. They will also have the chance to win a ZEISS EyeMag Smart in a prize draw.

Visualization systems and digital solutions for modern dental practices

In addition to the ZEISS EyeMag Family, the company will also present the OPMI PROergo^® and EXTARO^® 300 surgical microscopes at IDS in Cologne, Germany. In combination with digital solutions such as ZEISS Connect, ZEISS Surgical Cloud and ZEISS Livestream, the precision, efficiency and patient communication of the modern dental practice are supported.

ZEISS will showcase its visualization solutions for dentistry from March 25 to 29, 2025, at the IDS in Cologne, in Hall 10.1, F030 & G031.

Press & Investor Relations Contact Sebastian Frericks

Head of Group Finance & Investor Relations
Carl Zeiss Meditec AG
Phone: +49 3641 220 116
investors.med@zeiss.com

Brief profile

Carl Zeiss Meditec AG (ISIN: DE0005313704), which is listed on the MDAX and TecDAX of the German stock exchange, is one of the world's leading medical technology companies. The Company supplies innovative technologies and application-oriented solutions designed to help doctors improve the quality of life of their patients. The Company offers complete solutions, including implants and consumables, to diagnose and treat eye diseases. The Company creates innovative visualization solutions in the field of microsurgery. With 5,730 employees worldwide, the Group generated revenue of €2,066.1m in fiscal year 2023/24 (to 30 September).

The Group’s head office is located in Jena, Germany, and it has subsidiaries in Germany and abroad; more than 50 percent of its employees are based in the USA, Japan, Spain and France. The Center for Application and Research (CARIn) in Bangalore, India and the Carl Zeiss Innovations Center for Research and Development in Shanghai, China, strengthen the Company's presence in these rapidly developing economies. Around 39 percent of Carl Zeiss Meditec AG’s shares are in free float. Approx. 59 percent are held by Carl Zeiss AG, one of the world’s leading groups in the optical and optoelectronic industries.

For more information visit our website at www.zeiss.com/med